According to Vertex Pharmaceuticals's latest financial reports the company's total liabilities are $5.14 B. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2023-12-31 | $5.14 B | 21.51% |
2022-12-31 | $4.23 B | 27.18% |
2021-12-31 | $3.33 B | 8.73% |
2020-12-31 | $3.06 B | 37.25% |
2019-12-31 | $2.23 B | 23.34% |
2018-12-31 | $1.81 B | 20.42% |
2017-12-31 | $1.50 B | -3.52% |
2016-12-31 | $1.55 B | 10.94% |
2015-12-31 | $1.40 B | 13.44% |
2014-12-31 | $1.23 B | 28.66% |
2013-12-31 | $0.96 B | -38.43% |
2012-12-31 | $1.56 B | 22.55% |
2011-12-31 | $1.27 B | 4.45% |
2010-12-31 | $1.22 B | 42.17% |
2009-12-31 | $0.85 B | 15.85% |
2008-12-31 | $0.74 B | 124.6% |
2007-12-31 | $0.33 B | -20.56% |
2006-12-31 | $0.41 B | 34.16% |
2005-12-31 | $0.30 B | -39.25% |
2004-12-31 | $0.51 B | -4.05% |
2003-12-31 | $0.53 B | 21.6% |
2002-12-31 | $0.43 B | -2.81% |
2001-12-31 | $0.44 B |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $98.78 B | 1,818.21% | ๐บ๐ธ USA |
AbbVie ABBV | $124.31 B | 2,313.96% | ๐บ๐ธ USA |
Gilead Sciences GILD | $39.37 B | 664.61% | ๐บ๐ธ USA |
Merck MRK | $69.04 B | 1,240.63% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $65.67 B | 1,175.27% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | $0.23 B | -95.41% | ๐บ๐ธ USA |